This would include the induction of a fasting-like state [46] by SGLT2 inhibition
Homer CV, Tod AM, Thompson AR, Allmark P, Goyder E
Early and late-stage clinical trial coverage has reported major weight-loss results, and some discussions have focused on whether retatrutide may help support better body composition during weight loss
The compound has demonstrated generally good tolerability in clinical trials to date, with a safety profile largely consistent with other incretin-based therapies (GLP-1 and GLP-1/GIP agonists) that have become standard treatments for obesity and type 2 diabetes
While generally considered well-tolerated in many trials, its essential for individuals to discuss potential risks with a healthcare provider, as reactions can differ based on personal health and any existing conditions
By using GLP-1 injections, we can enhance these natural signals, making you feel fuller sooner and helping reduce cravings